CervoMed (CRVO) Total Debt (2010 - 2018)
CervoMed (CRVO) posted Total Debt of $550000.0 for Q1 2018, little changed sequentially from $550000.0 in Q4 2017, and down 70.74% YoY from $1.9 million in Q1 2017.
CervoMed (CRVO) Total Debt (2010 - 2018) Analysis & Trends
CervoMed has reported Total Debt for 9 years, with the latest figure at $550000.0 in Q1 2018.
- Quarterly Total Debt fell 70.74% year-over-year to $550000.0 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $550000.0 (down 70.74% YoY) and the FY2017 annual result came in at $550000.0, down 70.74% from the prior year.
- Total Debt held at $550000.0 in Q1 2018 per CRVO's latest filing, from $550000.0 in the prior quarter.
- Over five years, Total Debt peaked at $3.1 million in Q1 2014 and troughed at $50000.0 in Q3 2014.
- A 5-year average of $1.3 million and a median of $715000.0 in 2014 frame the typical range for Total Debt.
- The sharpest annual moves came in 2014 and 2016: Total Debt plunged 98.21% in 2014, then surged 342.39% in 2016.
- Over 5 years, Total Debt stood at $50000.0 in 2014, then surged by 749.93% to $424964.0 in 2015, then soared by 342.39% to $1.9 million in 2016, then plunged by 70.74% to $550000.0 in 2017, then changed by 0.0% to $550000.0 in 2018.
- According to Business Quant data, Total Debt over the past three periods registered $550000.0, $550000.0, and $550000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - | 9.34 Bn |
| 10 | CervoMed | 26.84 Mn | 26.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 550,000.00 |
| Dec 31, 2017 | 550,000.00 |
| Sep 30, 2017 | 550,000.00 |
| Jun 30, 2017 | 2.43 Mn |
| Mar 31, 2017 | 1.88 Mn |
| Dec 31, 2016 | 1.88 Mn |
| Sep 30, 2016 | 1.88 Mn |
| Dec 31, 2015 | 424,964.00 |
| Sep 30, 2014 | 50,000.00 |
| Jun 30, 2014 | 715,000.00 |
| Mar 31, 2014 | 3.09 Mn |
| Dec 31, 2013 | 3.33 Mn |
| Sep 30, 2013 | 2.79 Mn |
| Jun 30, 2013 | 2.29 Mn |
| Mar 31, 2013 | 4.44 Mn |
| Dec 31, 2012 | 4.22 Mn |
| Sep 30, 2012 | 3.63 Mn |
| Jun 30, 2012 | 2.86 Mn |
| Dec 31, 2011 | 739,163.00 |
| Sep 30, 2011 | 754,475.00 |